Skip to main content

Table 1 Baseline characteristics of the transplant patients

From: Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation

Characteristic Heart transplant patients
n= 60
Male sex 34 (56.7%)
Age (years) 42.1± 11.5
Weight (kg) 61.3 ± 13.4
Height (cm) 162.5 ± 10.3
Body surface area (m2) 1.7 ± 0.2
Primary disease
 Chagasic cardiomyopathy 22 (36.7%)
 Idiopathic dilated cardiomyopathy 21 (35.0%)
 Ischemic cardiomyopathy 7 (11.7%)
 Valvular cardiomyopathy 5 (8.3%)
 Hypertensive cardiomyopathy 4 (6.7%)
 CTRCD 1 (1.6%)
Hypertension 12 (20.0%)
Diabetes 12 (20.0%)
Smoking 17 (28.3%)
Time since transplantation (months) 6
Medication
 Corticosteroid 63 (95.5%)
 Mycophenolate mofetil 62 (93.9%)
 Tacrolimus 45 (68.2%)
 Cyclosporine 21 (31.8%)
 Sirolimus 4 (6.1%)
 Azathioprine 4 (6.1%)
 Statin 61 (92.4%)
 CCB 56 (84.5%)
 Betablocker 11 (16.7%)
 ACEI/ARB 11 (16.7%)
  1. The values are presented as the mean (standard deviation) or number (percentage)
  2. CTRCD Cancer therapeutic-related cardiac dysfunction; ACEI angiotensin converting enzyme inhibitor; ARB aldosterone receptor blocker; CCB calcium channel blocker